Hi Checho,
To comment on your question how the Bellamys takeover price was calculated just google "Bellamys Australia Limited Scheme Booklet" which is a letter from the directors of Bellamys to shareholders recommending acceptance of the takeover price.
The Independent expert " Grant Samuel" has provided an independent valuation commencing at page 72 and has used a discounted cash flow model to calculate enterprise value and then value per share. I.e. has used future free cash flows discounted for risk / return to estimate share price.
As a note of interest their share valuation is expressed as a multiple of EBITA at page 12 and is 29.6 times 2019 EBITA. Which is generous. Most takeovers are not that high. See page 12 for comparisons.
As a note of interest Mengniu's offer of $13.25 was a substantial premium to the share price but the fundamental valuation was on discounted cash flows.
The Scheme booklet is a tough read but very informative.
I have sold some a2 shares over the last week but still hold some.
- Forums
- ASX - By Stock
- Breaking the $6-00 Mark
A2M
the a2 milk company limited
Add to My Watchlist
0.51%
!
$7.80

Hi Checho,To comment on your question how the Bellamys takeover...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.80 |
Change
-0.040(0.51%) |
Mkt cap ! $5.647B |
Open | High | Low | Value | Volume |
$7.79 | $7.89 | $7.78 | $17.05M | 2.179M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7486 | $7.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.80 | 63 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7486 | 7.790 |
1 | 5486 | 7.780 |
4 | 16624 | 7.770 |
1 | 5486 | 7.760 |
4 | 2500 | 7.750 |
Price($) | Vol. | No. |
---|---|---|
7.800 | 63 | 1 |
7.850 | 11276 | 3 |
7.860 | 8714 | 2 |
7.870 | 7314 | 1 |
7.900 | 9918 | 6 |
Last trade - 16.20pm 26/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online